Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2/3 1Phase 1 1

Status

Completed 32Unknown 7Terminated 3Withdrawn 1Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 10Neoplasms 9Polycystic Ovary Syndrome 8Infertility 5Liver Neoplasms 4Pain, Postoperative 3Neoplasm Metastasis 3Multiple Myeloma 3Lung Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Recurrence 2Pulmonary Embolism 2Prostatic Neoplasms 2Pleural Effusion 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neuroma, Acoustic 2Melanoma 2Lymphoma, Follicular 2Leiomyoma 2Inflammation 2Febrile Neutropenia 2Colorectal Neoplasms 2Bites and Stings 2Anovulation 2Vomiting 1Venous Thrombosis 1Venous Thromboembolism 1

Interventions

tirbanibulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Withdrawn × Keratosis, Actinic × Clear all
NCT06026358 2024-05-30

Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands

Medical University of Graz

Phase 4 Withdrawn
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡